Worldwide: Healthcare

On May 22, 2025, the U.S. Department of Health and Human Services (HHS) announced the release of a new federal report, Making Our Children Healthy Again (MAHA Assessment)...

Children with medical complexity represent less than 1% of all children in the U.S., but have significant, specialized, and long-term health care needs, accounting for one-third of pediatrics costs in the U.S.

The Food and Drug Administration (FDA) decided not to appeal a district court decision issued on March 31 vacating the agency's final rule attempting to regulate laboratory developed tests (LDTs)...

On May 22, 2025, the U.S. Department of Health and Human Services (HHS) announced the release of a new federal report, Making Our Children Healthy Again (MAHA Assessment)...

The rapid growth of food delivery apps and quick commerce has driven India's e-commerce food industry to expand exponentially.

On the packaging for Balance of Nature dietary supplements, it says, "Real Food. Real Science. Real Nutrition." A consumer sued, alleging that these statements are false and misleading...

In light of graduation season and my recent article in Minnesota Lawyer discussing my mental health challenges, I wanted to write an open letter to my younger self.

On May 22, 2025, the U.S. Department of Health and Human Services (HHS) announced the release of a new federal report, Making Our Children Healthy Again (MAHA Assessment)...

Join Sheppard Mullin's Healthy AI team and Marsh McLennan for a CLE webinar addressing legal considerations...

On June 8, 2012, Genentech’s lawsuit seeking a declaration that US Patent No. 6,733,752 was invalid and not-infringed by Genentech’s trastuzumab product (HERCEPTIN).

Health Canada specifically contemplates certain proteins as SEBs in its Guidance, although Health Canada has not limited SEBs to only particular classes of drugs.

On May 23, 2012, the Federal Court held that Merck Frosst Canada Ltd. ("Merck") is liable to Apotex Inc. ("Apotex") for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the "Regulations"), but exercised its discretion to reduce the amount of compensation payable based on a defence of ex turpi causa.